Skip to main
GRAL

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 13%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL is poised for significant growth due to its multi-cancer early detection test, strong revenue guidance and partnership with Epic Aura. With a conservative guidance and the potential for a positive response from the oncology community for ASCO data and FDA approval, GRAIL is well-positioned for success in an underpenetrated market. Additionally, its materiality and potential for future growth make it an attractive investment opportunity.

Bears say

GRAIL is facing challenges with its declining ASPs and increasing volumes, leading to lower than expected revenue. This can be attributed to the company's reliance on discounting programs to engage customers and the potential for a slowdown in the self-pay market. On the upside, the company has a strong cash position and is seeing growth in prescribers, but there are risks related to FDA approval and Medicare reimbursement that could impact growth.

GRAIL Inc (GRAL) has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 8 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Aug 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.